Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-20-005776

EVP Pharmaceutical Oper & Tech gave up 351 shares (to pay taxes)

  • EVP Pharmaceutical Oper & Tech acquired 1,154 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Option exercise +484 1,912.26 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Shares withheld for taxes −153 $331.76 $50,759 1,759.26 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Option exercise +312 2,071.26 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Shares withheld for taxes −92 $331.76 $30,522 1,979.26 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Option exercise +358 2,337.26 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Shares withheld for taxes −106 $331.76 $35,167 2,231.26 D
Derivatives
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Grant or award · Restricted Stock Unit +6,780 6,780 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Option exercise · Restricted Stock Unit −484 0 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Option exercise · Restricted Stock Unit −312 902 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Other disposition · Restricted Stock Unit −294 608 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Option exercise · Restricted Stock Unit −358 1,982 D
Galdes Alphonse EVP Pharmaceutical Oper & Tech 2020-02-12 Other disposition · Restricted Stock Unit −420 1,562 D
Loading xslF345X03/form4.xml…